AstraZeneca plans US$ 570 million investment in Canada
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
Investment will fund expansion to meet rising demand for CRDMO services
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
Majority of organizations are looking to increase investments in public and hybrid cloud
Report highlights significant improvements in adolescent well-being in India
Ascentage Pharma announces confidential submission of draft registration statement for proposed IPO
Merck has opened its newly expanded Life Science distribution center in Schnelldorf, Germany
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
Cellectis is also eligible to receive an investigational new drug (IND) option fee and development
Subscribe To Our Newsletter & Stay Updated